Quick Takeaways
- This page summarizes Pascal Touchon's Form 4 filing for Atara Biotherapeutics, Inc. (ATRA).
- 2 reported transactions and 0 derivative rows are listed below.
- Filing timestamp: 20 Aug 2024, 18:27.
Pascal Touchon - 16 Aug 2024 Form 4 Insider Report for Atara Biotherapeutics, Inc. (ATRA)
- Signature
- /s/ John Chao, Attorney-in-Fact for Pascal Touchon
- Issuer symbol
- ATRA
- Transactions as of
- 16 Aug 2024
- Net transactions value
- -$20,139
- Form type
- 4
- Filing time
- 20 Aug 2024, 18:27:58 UTC
- Previous filing
- 14 Aug 2024
- Next filing
- 12 Jun 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Pascal Touchon filed Form 4 for Atara Biotherapeutics, Inc. (ATRA) on 20 Aug 2024."
What Changed
- Previous filing in this sequence was filed on 14 Aug 2024.
- Current net transaction value: -$20,139.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Source Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Transactions Table
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ATRA | Common Stock | Sale | $18,309 | -2,762 | -3.8% | $6.63 | 70,403 | 16 Aug 2024 | Direct | F1, F2, F3 |
| transaction | ATRA | Common Stock | Sale | $1,830 | -276 | -0.39% | $6.63 | 70,127 | 16 Aug 2024 | Direct | F1, F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement. |
| F2 | The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on August 16, 2024 and August 19, 2024 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees. |
| F3 | This amount reflects the 1:25 reverse stock split effected by the Issuer on June 20, 2024. |